FI932491A - Vaccin mot Neisseria meningitidis-infektioner - Google Patents
Vaccin mot Neisseria meningitidis-infektioner Download PDFInfo
- Publication number
- FI932491A FI932491A FI932491A FI932491A FI932491A FI 932491 A FI932491 A FI 932491A FI 932491 A FI932491 A FI 932491A FI 932491 A FI932491 A FI 932491A FI 932491 A FI932491 A FI 932491A
- Authority
- FI
- Finland
- Prior art keywords
- receptor
- antiserum
- recognised
- pct
- meningitidis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/871—Neisseria
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9112177 | 1991-10-03 | ||
| FR9112177A FR2682041B1 (fr) | 1991-10-03 | 1991-10-03 | Vaccin contre les infections a neisseria meningitidis. |
| PCT/FR1992/000905 WO1993006861A1 (fr) | 1991-10-03 | 1992-09-29 | VACCIN CONTRE LES INFECTIONS A $i(NEISSERIA MENINGITIDIS) |
| FR9200905 | 1992-09-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI932491A true FI932491A (fi) | 1993-06-01 |
| FI932491A0 FI932491A0 (fi) | 1993-06-01 |
| FI107233B FI107233B (fi) | 2001-06-29 |
Family
ID=9417549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI932491A FI107233B (fi) | 1991-10-03 | 1993-06-01 | Menetelmä farmaseuttisen rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5618541A (fi) |
| EP (1) | EP0560968B1 (fi) |
| JP (1) | JPH06503365A (fi) |
| AT (1) | ATE140626T1 (fi) |
| AU (1) | AU662176B2 (fi) |
| CA (1) | CA2097056A1 (fi) |
| DE (1) | DE69212459T2 (fi) |
| DK (1) | DK0560968T3 (fi) |
| ES (1) | ES2090696T3 (fi) |
| FI (1) | FI107233B (fi) |
| FR (1) | FR2682041B1 (fi) |
| HU (1) | HU219673B (fi) |
| NO (1) | NO306538B1 (fi) |
| WO (1) | WO1993006861A1 (fi) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2682114B1 (fr) * | 1991-10-03 | 1996-02-23 | Pasteur Merieux Serums Vacc | Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie. |
| FR2692592B1 (fr) * | 1992-06-19 | 1995-03-31 | Pasteur Merieux Serums Vacc | Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant. |
| CN1990503A (zh) * | 1993-11-08 | 2007-07-04 | 康诺特实验室有限公司 | 嗜血杆菌属转铁蛋白受体基因 |
| FR2720408B1 (fr) * | 1994-05-31 | 1996-08-14 | Pasteur Merieux Serums Vacc | Fragments Tbp2 de Neisseria meningitidis. |
| FR2739624B1 (fr) * | 1995-10-10 | 1997-12-05 | Pasteur Merieux Serums Vacc | Nouvelle sous-unite tbp2 de neisseria meningitidis |
| US6290970B1 (en) * | 1995-10-11 | 2001-09-18 | Aventis Pasteur Limited | Transferrin receptor protein of Moraxella |
| US6087036A (en) | 1997-07-25 | 2000-07-11 | 3M Innovative Properties Company | Thermal management system and method for a solid-state energy storing device |
| FR2767060B1 (fr) * | 1997-08-07 | 2000-02-11 | Pasteur Merieux Serums Vacc | Vaccin meningocoque comportant la valence de souche bz83 |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| GB9808866D0 (en) | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| FR2785293B1 (fr) * | 1998-10-30 | 2002-07-05 | Pasteur Merieux Serums Vacc | Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria |
| US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
| GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
| KR101239242B1 (ko) | 2002-08-02 | 2013-03-11 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 항원 조합물을 포함하는 나이세리아 백신 조성물 |
| US8409587B2 (en) | 2002-11-01 | 2013-04-02 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| BRPI0415025A (pt) | 2003-10-02 | 2006-12-12 | Chiron Srl | vacinas lìquidas para sorogrupos meningocócicos múltiplos |
| EP1667712B1 (en) | 2003-10-02 | 2010-07-21 | GlaxoSmithKline Biologicals S.A. | B. pertussis antigens and use thereof in vaccination |
| GB0505996D0 (en) | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
| DE602007003596D1 (de) | 2006-06-12 | 2010-01-14 | Glaxosmithkline Biolog Sa | Impfstoff |
| GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
| CA2792683A1 (en) | 2010-03-10 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Neisserial fhbp vaccine composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
| US5292869A (en) * | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
-
1991
- 1991-10-03 FR FR9112177A patent/FR2682041B1/fr not_active Expired - Fee Related
-
1992
- 1992-09-29 US US08/066,167 patent/US5618541A/en not_active Expired - Lifetime
- 1992-09-29 AU AU27624/92A patent/AU662176B2/en not_active Ceased
- 1992-09-29 AT AT92921362T patent/ATE140626T1/de active
- 1992-09-29 HU HU9301630A patent/HU219673B/hu not_active IP Right Cessation
- 1992-09-29 WO PCT/FR1992/000905 patent/WO1993006861A1/fr active IP Right Grant
- 1992-09-29 EP EP92921362A patent/EP0560968B1/fr not_active Expired - Lifetime
- 1992-09-29 DK DK92921362.7T patent/DK0560968T3/da active
- 1992-09-29 CA CA002097056A patent/CA2097056A1/en not_active Abandoned
- 1992-09-29 JP JP5506653A patent/JPH06503365A/ja active Pending
- 1992-09-29 DE DE69212459T patent/DE69212459T2/de not_active Expired - Lifetime
- 1992-09-29 ES ES92921362T patent/ES2090696T3/es not_active Expired - Lifetime
-
1993
- 1993-06-01 FI FI932491A patent/FI107233B/fi active
- 1993-06-02 NO NO932010A patent/NO306538B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69212459D1 (de) | 1996-08-29 |
| ATE140626T1 (de) | 1996-08-15 |
| HUT69980A (en) | 1995-09-28 |
| CA2097056A1 (en) | 1993-04-04 |
| ES2090696T3 (es) | 1996-10-16 |
| DK0560968T3 (da) | 1996-11-25 |
| FI932491A0 (fi) | 1993-06-01 |
| AU662176B2 (en) | 1995-08-24 |
| FR2682041B1 (fr) | 1994-01-14 |
| WO1993006861A1 (fr) | 1993-04-15 |
| NO306538B1 (no) | 1999-11-22 |
| EP0560968A1 (en) | 1993-09-22 |
| EP0560968B1 (fr) | 1996-07-24 |
| DE69212459T2 (de) | 1996-12-05 |
| NO932010D0 (no) | 1993-06-02 |
| HU219673B (hu) | 2001-06-28 |
| JPH06503365A (ja) | 1994-04-14 |
| FR2682041A1 (fr) | 1993-04-09 |
| US5618541A (en) | 1997-04-08 |
| NO932010L (no) | 1993-06-02 |
| FI107233B (fi) | 2001-06-29 |
| AU2762492A (en) | 1993-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI932491A (fi) | Vaccin mot Neisseria meningitidis-infektioner | |
| KR880000098A (ko) | 콘드로이틴 설페이트 면역자극 조성물 | |
| FR2727015B1 (fr) | Compositions pharmaceutiques liquides a base d'ondansetron | |
| MY101207A (en) | Treatment of diseases caused by retroviruses | |
| DE69127470D1 (de) | Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen | |
| FR2714378B1 (fr) | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. | |
| NO985975L (no) | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav | |
| DE69331495D1 (de) | Impfstoffe gegen neisseria meningitidis gruppe c | |
| DK1378245T3 (da) | Transferrin-bindende-proteiner fra neisseria gonorrhoeae og neisseria meningitidis. Deres anvendelse i en vaccine | |
| DK0733046T3 (da) | Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter | |
| UA27848C2 (uk) | Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну | |
| FI932490A0 (fi) | Underenhetsvaccin mot Neisseria meningitidis-infektioner och motsvarande underenheter i rent tillstaond | |
| DE58906232D1 (de) | Azelastin enthaltende Arzneimittel mit kontrollierter Wirkstoffabgabe. | |
| DK0508993T3 (da) | Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derfor | |
| FR2662942B1 (fr) | Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae. | |
| IL117564A (en) | Pharmaceutical and diagnostic compositions containing lysine derivatives | |
| EP0344980A3 (en) | Alpha-adrenergic receptor antagonists | |
| ENDO | On the relationship between deciduous tooth eruption and the stature and weight of infants | |
| Tablets | in u| i~ nary infections ‘clearly superior’ |